Skip to main content
TipRanks
Go Ultimate75% OFF

verbio Vereinigte BioEnergie (VBK) AI Stock Analysis

56 Followers
DE:VBK

verbio Vereinigte BioEnergie

(XETRA:VBK)

Select Model
Rating:63Neutral
Price Target:EUR 25.00â–²(5.49% Upside)
Action:reiterated
Date:11/16/26

The score is supported primarily by improving financial performance (profitability and cash flow recovery with manageable leverage) and a constructive earnings outlook (upper-end EBITDA guidance and stronger cash generation). Offsetting this, technical signals remain weak with the stock trading well below major moving averages and negative MACD, while valuation appears only moderate with no dividend data provided.

Positive Factors
Profitability and cash-flow recoveryThe rebound in revenue, profitability, and cash generation indicates that Verbio has recovered materially from FY2025 weakness. Positive operating and free cash flow improve internal funding capacity, support investment in growth projects, and strengthen resilience over the next several quarters.
Negative Factors
Cyclical earnings and cash-flow durabilityThe recovery remains exposed to the business’s historical volatility, so current margins and cash generation may not persist through changing feedstock, fuel, and quota conditions. Uneven prior performance makes long-term earnings visibility and investment planning less predictable.

verbio Vereinigte BioEnergie (VBK) vs. iShares MSCI Germany ETF (EWG)

-50%0%50%100%150%200%DE:VBK+44.16%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.52B
Dividend Yield
―
Average Volume (3M)
98.65K
Price to Earnings (P/E)
14.6
Beta (1Y)
0.19
Revenue Growth
18.55%
EPS Growth
―
Country
Germany
Employees
1,394
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

verbio Vereinigte BioEnergie Business Overview & Revenue Model

Company Description

VERBIO Vereinigte BioEnergie AG operates as a prominent producer and supplier of sustainable biofuels throughout Germany and the broader European market. The firm's diverse portfolio features products such as biodiesel, bioethanol, biomethane, bioste...

verbio Vereinigte BioEnergie Earnings Call Summary

Earnings Call Date:Nov 12, 2026(Q1-2027)|% Change Since:-9.61%|Next Earnings Date:Feb 11, 2027
Earnings Call SentimentPositive

The call was clearly positive overall. Management reported a substantial year-on-year improvement in EBITDA, a swing to positive operating and free cash flow, lower net debt, stronger biodiesel markets, and increased confidence in achieving the upper end of the EUR 210 million to EUR 250 million EBITDA guidance range. Regulatory developments in Germany and Europe, Canadian production prospects, India expansion, and potential U.S. 45Z tax credits were additional positives. Offsetting issues included lower bioethanol production, weaker European bioethanol margins, temporary North American production problems, pressure and uncertainty in greenhouse gas quota pricing, below-full utilization at some U.S. plants, and the long commissioning timeline for Bitterfeld. The highlights significantly outweighed the lowlights.

Positive Updates

Strong Start and Higher EBITDA Guidance
Management described the first quarter as a strong start, with significantly improved underlying profitability and positive cash flow. Following the better-than-expected quarter and continued strong biodiesel spreads in Europe and North America, the company expects full-year 2026/27 EBITDA at the upper end of its EUR 210 million to EUR 250 million guidance range.

Negative Updates

Bioethanol Production Declined Year on Year
Bioethanol production was slightly lower year on year at 147,000 tonnes, mainly due to lower European production, lower yields, and technical issues during the summer.

Company Guidance

Management now expects group EBITDA for 2026, 2027 to come in at the upper end of its guidance range of EUR 210 million to EUR 250 million, with the first quarter performance not indicative for the full year run rate, a meaningful contribution from the greenhouse gas quota business, strong cash generation and a further significant reduction in net debt; it expects 2027 quota prices to be surely between EUR 400 and EUR 500, with the obligation growing by 5.5%, from EUR 12 million to EUR 17.5 million, while final 45Z guidance is expected in December and is not yet included. Management expects margins to stay on that level, with upside potential, expects to ramp both North American plants to full capacity, plans around about $30 million of investment in South Bend in 2027, expects first saleable Bitterfeld ethenolysis products at the end of November, December, and is planning to build up to 2 new plants in India.

verbio Vereinigte BioEnergie Financial Statement Overview

Summary

Financials show a clear rebound versus FY2025: TTM revenue growth (~5.1%) and improved profitability (gross margin ~18.2%, net margin ~5.3%) support recovery, leverage is modest (debt-to-equity ~0.22) with ROE back to ~13.1%, and TTM free cash flow is positive (~129m). Offsetting this, earnings and cash flow have been uneven across years (including prior negative FCF), so durability through the cycle remains a key risk.

Income Statement

71Positive

Balance Sheet

78Positive

Cash Flow

66Positive
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.97B1.87B1.58B1.67B1.97B1.81B
Gross Profit358.77M336.50M37.12M292.45M381.91M626.92M
EBITDA243.11M184.83M-54.41M122.92M242.68M494.81M
Net Income104.02M63.92M-138.01M19.96M132.02M315.63M
Balance Sheet
Total Assets1.43B1.37B1.28B1.38B1.30B1.13B
Cash, Cash Equivalents and Short-Term Investments89.35M90.30M64.41M126.70M170.31M300.50M
Total Debt187.73M221.34M268.86M194.20M189.97M49.39M
Total Liabilities571.52M552.08M536.78M449.54M385.36M310.16M
Stockholders Equity855.70M816.68M746.29M925.67M909.47M816.23M
Cash Flow
Free Cash Flow129.30M78.37M-117.96M-54.38M-177.12M210.15M
Operating Cash Flow215.92M164.56M13.88M116.78M26.09M325.03M
Investing Cash Flow-74.16M-75.27M-120.06M-144.90M-266.43M-113.62M
Financing Cash Flow-123.78M-64.08M49.88M-19.53M112.21M-18.48M

verbio Vereinigte BioEnergie Technical Analysis

Technical Analysis SentimentNegative
Last Price23.70

Price Trends

50DMA28.31Negative
100DMA29.53Negative
200DMA31.84Negative

Market Momentum

MACD-0.88Positive
RSI33.36Neutral
STOCH17.60Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Negative. The current price of 23.70 is below the 20-day moving average (MA) of 27.29, below the 50-day MA of 28.31, and below the 200-day MA of 31.84, indicating a bearish trend. The MACD of -0.88 indicates Positive momentum. The RSI at 33.36 is Neutral, neither overbought nor oversold. The STOCH value of 17.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:VBK.

verbio Vereinigte BioEnergie Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

DE:VBK against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:FPEDE:FPE69NeutralEUR 5.39B16.0917.37%3.21%12.08%21.84%
DE:BNRDE:BNR65NeutralEUR 8.47B22.308.53%3.24%0.32%-8.91%
DE:EVKDE:EVK64NeutralEUR 9.94B56.312.16%4.69%1.98%83.13%
DE:VBKDE:VBK63NeutralEUR 1.52B14.6313.07%―18.55%―
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
DE:WCHDE:WCH54NeutralEUR 4.01B-14.89-6.82%3.10%――
DE:LXSDE:LXS43NeutralEUR 1.14B-1.71-18.99%0.76%-3.63%-172.43%

* General Sector Average

Performance Comparison

0%50%100%150%DE:VBKDE:BNRDE:EVKDE:FPEDE:LXSDE:WCHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:VBK and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:VBKverbio Vereinigte BioEnergie23.707.1242.94%
DE:BNRBrenntag AG (UK)58.6611.9825.66%
DE:EVKEvonik Industries AG21.328.7669.69%
DE:FPEFuchs Petrolub38.058.9430.72%
DE:LXSLanxess (OTC)13.15-3.29-20.03%
DE:WCHWacker Chemie Ag (OTC)80.7013.4520.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 16, 2026